636 related articles for article (PubMed ID: 22122739)
1. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
2. Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer.
Hermansen DK; Badalament RA; Bretton PR; Kimmel M; Aswad CM; Whitmore WF; Melamed MR
J Occup Med; 1990 Sep; 32(9):894-7. PubMed ID: 2074515
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonography compared with intravenous urography in the investigation of adults with haematuria.
Spencer J; Lindsell D; Mastorakou I
BMJ; 1990 Nov; 301(6760):1074-6. PubMed ID: 2249070
[TBL] [Abstract][Full Text] [Related]
4. A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy.
de Jong FC; Iflé IG; van der Made AC; Kooper D; de Jong JJ; Franckena M; Zuiverloon TCM; van Criekinge W; Incrocci L; Zwarthoff EC; Boormans JL
Eur Urol Open Sci; 2024 Apr; 62():131-139. PubMed ID: 38496820
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study of the sensitivity of bladder washing flow cytometry, voided urine cytology and bladder washing cytology in the detection of bladder carcinoma].
Tachibana M; Jitsukawa S; Tazaki H; Tashiro Y
Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1025-30. PubMed ID: 2607716
[TBL] [Abstract][Full Text] [Related]
6. Urinary cytology in the detection of bladder carcinoma.
O'Donoghue JM; Horgan PG; Corcoran M; Bredin H; McGuire M; Given HF
Ir J Med Sci; 1991 Nov; 160(11):352-3. PubMed ID: 1810904
[TBL] [Abstract][Full Text] [Related]
7. Current status of urinary cytology in the evaluation of bladder neoplasms.
Murphy WM
Hum Pathol; 1990 Sep; 21(9):886-96. PubMed ID: 2203672
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers.
Jiang C; Li X; Chen R; Yang Y; Wang Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):169. PubMed ID: 38546889
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor.
Palermo M; D'Elia C; Trenti E; Comploj E; Mian C; Schwienbacher C; Heidegger I; Clauser S; Pycha A; Vjaters E
Minerva Urol Nephrol; 2024 Mar; ():. PubMed ID: 38498297
[TBL] [Abstract][Full Text] [Related]
10. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.
Kim PH; Sukhu R; Cordon BH; Sfakianos JP; Sjoberg DD; Hakimi AA; Dalbagni G; Lin O; Herr HW
BJU Int; 2014 Sep; 114(3):354-9. PubMed ID: 24128299
[TBL] [Abstract][Full Text] [Related]
11. Roentgenologic aspects of haematuria.
Jonsson K; Owman T
Scand J Urol Nephrol; 1976; 10(3):229-34. PubMed ID: 1006185
[TBL] [Abstract][Full Text] [Related]
12. Bladder tumor control by abdominal ultrasound and urine cytology.
Berlac PA; Holm HH
J Urol; 1992 Jun; 147(6):1510-2. PubMed ID: 1593677
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in patients with neoplastic urinary bladder diverticula: A major cancer center experience.
Alhamar M; Al-Ahmadie HA; Feratovic R; Lin O
Cancer Cytopathol; 2024 Mar; 132(3):144-151. PubMed ID: 38054371
[TBL] [Abstract][Full Text] [Related]
14. B5 tumour marker and urine cytology in diagnosis and follow-up of transitional cell bladder cancer.
Malpani K; Metcalfe SM; Hinchliffe A
Br J Urol; 1989 Sep; 64(3):257-62. PubMed ID: 2804562
[TBL] [Abstract][Full Text] [Related]
15. Advances in screening protocols for the detection of early bladder cancer.
Geller AC; Brooks DR; Barber CE; Koh HK; Lew RA; Wax S; Prout MN
J Occup Med; 1990 Sep; 32(9):929-35. PubMed ID: 2074522
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of URO17® to improve non-invasive detection of bladder cancer.
Porten SP; Wang EY; Vohra P; Carroll PR; Jahanfard S; Kim NW
Urol Oncol; 2024 Jun; 42(6):176.e21-176.e28. PubMed ID: 38553264
[TBL] [Abstract][Full Text] [Related]
17. Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy.
Hourigan SK; Zhu W; S W Wong W; Clemency NC; Provenzano M; Vilboux T; Niederhuber JE; Deeken J; Chung S; McDaniel-Wiley K; Trump D
BMC Urol; 2020 Jan; 20(1):5. PubMed ID: 31992287
[TBL] [Abstract][Full Text] [Related]
18. Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle-invasive bladder cancer.
Krishnatry R; Maitre P; Kumar A; Telkhade T; Bakshi G; Prakash G; Pal M; Joshi A; Menon S; Murthy V
Cancer Med; 2023 May; 12(10):11305-11314. PubMed ID: 36965102
[TBL] [Abstract][Full Text] [Related]
19. Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery.
Gómez Del Cañizo C; González Ginel I; Martín-Arriscado Arroba C; de la Calle Moreno A; Hernández Arroyo M; Rodríguez Antolín A; Guerrero Ramos F
Urol Oncol; 2024 Apr; ():. PubMed ID: 38664179
[TBL] [Abstract][Full Text] [Related]
20. Clinical Validation of the Proenkephalin (
Han H; Oh TJ; Heo JE; Lee J; Jang WS; Lee SH; Ham WS; Hwang J; An S; Choi YD
Eur Urol Open Sci; 2024 Apr; 62():99-106. PubMed ID: 38496823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
